Vistagen Therapeutics Inc (VTGN)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current VTGN market cap is 85.19M. The company's latest EPS is USD -1.0853 and P/E is -2.83.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 178k | 277k | 412k | 197k | 84k |
| Operating Income | -7M | -6.78M | -7.88M | -11.36M | -12.13M |
| Net Income | -6.9M | -6.59M | -6.35M | -9.52M | -10.73M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.09M | 1.11M | -227k | 1.06M |
| Operating Income | -20.8M | -17.93M | -47.78M | -59.27M | -33.02M |
| Net Income | -22.04M | -42.32M | -48.71M | -59.25M | -29.36M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.03M | 42.2M | 131.07M | 123.65M | 113.55M |
| Total Liabilities | 8.18M | 6.55M | 7.78M | 9.37M | 8.75M |
| Total Equity | 6.85M | 35.65M | 123.29M | 114.29M | 104.8M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.77M | 108.28M | 74.64M | 21.09M | 123.65M |
| Total Liabilities | 11.5M | 16.3M | 9.93M | 9.01M | 9.37M |
| Total Equity | -5.73M | 91.98M | 64.72M | 12.08M | 114.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.89M | -14.08M | -18.62M | -25.81M | -10.87M |
| Investing | N/A | N/A | -32k | -61k | -5.47M |
| Financing | 875k | 35.05M | 128.57M | 128.4M | 88k |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.76M | -12.07M | -45.26M | -49.72M | -25.81M |
| Investing | N/A | -275k | -200k | -740k | -61k |
| Financing | 4.01M | 114.1M | 10.48M | -1.04M | 128.4M |
| Market Cap | 85.19M |
| Price to Earnings Ratio | -2.83 |
| Price to Sales Ratio | 78.12 |
| Price to Cash Ratio | 0.7 |
| Price to Book Ratio | 0.73 |
| Dividend Yield | - |
| Shares Outstanding | 27.06M |
| Average Volume (1 week) | 192.11k |
| Average Volume (1 Month) | 116.42k |
| 52 Week Change | -39.56% |
| 52 Week High | 5.86 |
| 52 Week Low | 2.4501 |
| Spread (Intraday) | 0.07 (2.18%) |
| Company Name | Vistagen Therapeutics Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.vistagen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
